CD4 dependence of gp120IIIB-CXCR4 interaction is cell-type specific

Journal of Neuroimmunology

Volumn 140, Issue 1-2, 2003, Pages 1-12

  Bodner, Amos ^a   Toth, Peter T ^a   Oh, Seog Bae ^a   Lu, Meiling ^a   Tran, Phuong B ^a   Chin, Robert K ^b   Ren, Dongjun ^a   Miller, Richard J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

AIDS; AMD3100; Apoptosis; Chemokine receptor; Confocal microscopy; Internalization

Indexed keywords

CALCIUM CHANNEL; CALCIUM CHANNEL N TYPE; CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; GLYCOPROTEIN GP 120; PROTEIN SUBUNIT; STROMAL CELL DERIVED FACTOR 1ALPHA;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL SPECIFICITY; CELL STRAIN; CELL TYPE; CONTROLLED STUDY; EMBRYO; ENDOCYTOSIS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MOUSE; NERVE CELL CULTURE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 0038643825     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(03)00162-0     Document Type: Article

References (65)

1. Adle-Biassette H., Levy Y., Colombel M., Poron F., Natchev S., Keohane C., Gray F. Neuronal apoptosis in HIV infection in adults. Neuropathol. Appl. Neurobiol. 21:1995;218-227.
2. Bajetto A., Bonavia R., Barbero S., Florio T., Schettini G. Chemokines and their receptors in the central nervous system. Front. Neuroendocrinol. 22:2001;147-184.
3. Banisadr G., Dicou E., Berbar T., Rostene W., Lombet A., Haour F. Characterization and visualization of [125I] stromal cell-derived factor-1alpha binding to CXCR4 receptors in rat brain and human neuroblastoma cells. J. Neuroimmunol. 110:2000;151-160.
4. Berger E.A., Murphy P.M., Farber J.M. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17:1999;657-700.
5. Bezzi P., Domercq M., Brambilla L., Galli R., Schols D., De Clercq E., Vescovi A., Bagetta G., Kollias G., Meldolesi J., Volterra A. CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat. Neurosci. 4:2001;702-710.
6. Brown D.A., London E. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J. Biol. Chem. 275:2000;17221-17224.
7. Chard P.S., Bleakman D., Christakos S., Fullmer C.S., Miller R.J. Calcium buffering properties of calbindin D28k and parvalbumin in rat sensory neurones. J. Physiol. 472:1993;341-357.
8. Conklin B.R., Farfel Z., Lustig K.D., Julius D., Bourne H.R. Substitution of three amino acids switches receptor specificity of Gq alpha to that of Gi alpha. Nature. 363:1993;274-276.
9. Corasaniti M.T., Maccarrone M., Nistico R., Malorni W., Rotiroti D., Bagetta G. Exploitation of the HIV-1 coat glycoprotein, gp120, in neurodegenerative studies in vivo. J. Neurochem. 79:2001;1-8.
10. Davis S.J., James W.S., Schockmel G.A., Simon J.H., Somoza C. The recognition of chimeras of rat and human CD4 by HIV-1 gp120 and by monoclonal antibodies. Philos. Trans. R. Soc. Lond., B Biol. Sci. 342:1993;75-81.
11. Davis C.B., Dikic I., Unutmaz D., Hill C.M., Arthos J., Siani M.A., Thompson D.A., Schlessinger J., Littman D.R. Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. J. Exp. Med. 186:1997;1793-1798.
12. Doms R.W. Beyond receptor expression: the influence of receptor conformation, density, and affinity in HIV-1 infection. Virology. 276:2000;229-237.
13. Esser M.T., Bess J.W. Jr., Suryanarayana K., Chertova E., Marti D., Carrington M., Arthur L.O., Lifson J.D. Partial activation and induction of apoptosis in CD4(+) and CD8(+) T lymphocytes by conformationally authentic noninfectious human immunodeficiency virus type 1. J. Virol. 75:2001;1152-1164.
14. Everall I.P., Heaton R.K., Marcotte T.D., Ellis R.J., McCutchan J.A., Atkinson J.H., Grant I., Mallory M., Masliah E. Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center. Brain Pathol. 9:1999;209-217.
15. Francel P.C., Harris K., Smith M., Fishman M.C., Dawson G., Miller R.J. Neurochemical characteristics of a novel dorsal root ganglion X neuroblastoma hybrid cell line, F-11. J. Neurochem. 48:1987;1624-1631.
16. Gallo S.A., Puri A., Blumenthal R. HIV-1 gp41 six-helix bundle formation occurs rapidly after the engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process. Biochemistry. 40:2001;12231-12236.
17. Ganju R.K., Dutt P., Wu L., Newman W., Avraham H., Avraham S., Groopman J.E. Beta-chemokine receptor CCR5 signals via the novel tyrosine kinase RAFTK. Blood. 91:1998;791-797.
18. Geijtenbeek T.B., Kwon D.S., Torensma R., van Vliet S.J., van Duijnhoven G.C., Middel J., Cornelissen I.L., Nottet H.S., KewalRamani V.N., Littman D.R., Figdor C.G., van Kooyk Y. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell. 100:2000;587-597.
19. Gelbard H.A., James H.J., Sharer L.R., Perry S.W., Saito Y., Kazee A.M., Blumberg B.M., Epstein L.G. Apoptotic neurons in brains from paediatric patients with HIV-1 encephalitis and progressive encephalopathy. Neuropathol. Appl. Neurobiol. 21:1995;208-217.
20. Gimpl G., Fahrenholz F. Human oxytocin receptors in cholesterol-rich vs. cholesterol-poor microdomains of the plasma membrane. Eur. J. Biochem. 267:2000;2483-2497.
21. Gorry P.R., Taylor J., Holm G.H., Mehle A., Morgan T., Cayabyab M., Farzan M., Wang H., Bell J.E., Kunstman K., Moore J.P., Wolinsky S.M., Gabuzda D. Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate. J. Virol. 76:2002;6277-6292.
22. Hager-Braun C., Tomer K.B. Characterization of the tertiary structure of soluble CD4 bound to glycosylated full-length HIVgp120 by chemical modification of arginine residues and mass spectrometric analysis. Biochemistry. 41:2002;1759-1766.
23. Hamill O.P., Marty A., Neher E., Sakmann B., Sigworth F.J. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 391:1981;85-100.
24. Hao H.N., Chiu F.C., Losev L., Weidenheim K.M., Rashbaum W.K., Lyman W.D. HIV infection of human fetal neural cells is mediated by gp120 binding to a cell membrane-associated molecule that is not CD4 nor galactocerebroside. Brain Res. 764:1997;149-157.
25. Hatse S., Princen K., Bridger G., De Clercq E., Schols D. Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4. FEBS Lett. 527:2002;255-262.
26. Herbein G., Mahlknecht U., Batliwalla F., Gregersen P., Pappas T., Butler J., O'Brien W.A., Verdin E. Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4. Nature. 395:1998;189-194.
27. Hesselgesser J., Halks-Miller M., DelVecchio V., Peiper S.C., Hoxie J., Kolson D.L., Taub D., Horuk R. CD4-independent association between HIV-1 gp120 and CXCR4: functional chemokine receptors are expressed in human neurons. Curr. Biol. 7:1997;112-121.
28. Kaul M., Lipton S.A. Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc. Natl. Acad. Sci. U. S. A. 96:1999;8212-8216.
29. Kaul M., Garden G.A., Lipton S.A. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature. 410:2001;988-994.
30. Kramer H.K., Simon E.J. mu and delta-opioid receptor agonists induce mitogen-activated protein kinase (MAPK) activation in the absence of receptor internalization. Neuropharmacology. 39:2000;1707-1719.
31. Kurschner C., Yuzaki M. Neuronal interleukin-16 (NIL-16): a dual function PDZ domain protein. J. Neurosci. 19:1999;7770-7780.
32. Kwong P.D., Wyatt R., Robinson J., Sweet R.W., Sodroski J., Hendrickson W.A. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature. 393:1998;648-659.
33. Lannuzel A., Barnier J.V., Hery C., Huynh V.T., Guibert B., Gray F., Vincent J.D., Tardieu M. Human immunodeficiency virus type 1 and its coat protein gp120 induce apoptosis and activate JNK and ERK mitogen-activated protein kinases in human neurons. Ann. Neurol. 42:1997;847-856.
34. Lazarini F., Casanova P., Tham T.N., De Clercq E., Arenzana-Seisdedos F., Baleux F., Dubois-Dalcq M. Differential signalling of the chemokine receptor CXCR4 by stromal cell-derived factor 1 and the HIV glycoprotein in rat neurons and astrocytes. Eur. J. Neurosci. 12:2000;117-125.
35. Madani N., Kozak S.L., Kavanaugh M.P., Kabat D. gp120 envelope glycoproteins of human immunodeficiency viruses competitively antagonize signaling by coreceptors CXCR4 and CCR5. Proc. Natl. Acad. Sci. U. S. A. 95:1998;8005-8010.
36. Masliah E., Heaton R.K., Marcotte T.D., Ellis R.J., Wiley C.A., Mallory M., Achim C.L., McCutchan J.A., Nelson J.A., Atkinson J.H., Grant I. Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann. Neurol. 42:1997;963-972.
37. McDonald P.H., Lefkowitz R.J. Beta-arrestins: new roles in regulating heptahelical receptors' functions. Cell. Signal. 13:2001;683-689.
38. Meucci O., Miller R.J. gp120-induced neurotoxicity in hippocampal pyramidal neuron cultures: protective action of TGF-beta1. J. Neurosci. 16:1996;4080-4088.
39. Meucci O., Fatatis A., Simen A.A., Bushell T.J., Gray P.W., Miller R.J. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc. Natl. Acad. Sci. U. S. A. 95:1998;14500-14505.
40. Miller R.J., Meucci O. AIDS and the brain: is there a chemokine connection? Trends Neurosci. 22:1999;471-479.
41. Miller R., Oh S. Why do neurons express chemokine receptors? Ransohoff R.M., Suzuki K., Proudfoot A.E.I., Hickey W.F., Harrison J.K. Universes in Delicate Balance: Chemokines and the Nervous System. 2002;273-288 Elsevier, Amsterdam.
42. Misse D., Cerutti M., Noraz N., Jourdan P., Favero J., Devauchelle G., Yssel H., Taylor N., Veas F. A CD4-independent interaction of human immunodeficiency virus-1 gp120 with CXCR4 induces their cointernalization, cell signaling, and T-cell chemotaxis. Blood. 93:1999;2454-2462.
43. Oh S.B., Tran P.B., Gillard S.E., Hurley R.W., Hammond D.L., Miller R.J. Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J. Neurosci. 21:2001;5027-5035.
44. Oh S.B., Endoh T., Simen A.A., Ren D., Miller R.J. Regulation of calcium currents by chemokines and their receptors. J. Neuroimmunol. 123:2002;66-75.
45. Pandey V., Bolsover S.R. Immediate and neurotoxic effects of HIV protein gp120 act through CXCR4 receptor. Biochem. Biophys. Res. Commun. 274:2000;212-215.
46. Parada N.A., Cruikshank W.W., Danis H.L., Ryan T.C., Center D.M. IL-16- and other CD4 ligand-induced migration is dependent upon protein kinase C. Cell. Immunol. 168:1996;100-106.
47. Parolin C., Borsetti A., Choe H., Farzan M., Kolchinsky P., Heesen M., Ma Q., Gerard C., Palu G., Dorf M.E., Springer T., Sodroski J. Use of murine CXCR-4 as a second receptor by some T-cell-tropic human immunodeficiency viruses. J. Virol. 72:1998;1652-1656.
48. Petito C.K., Roberts B. Evidence of apoptotic cell death in HIV encephalitis. Am. J. Pathol. 146:1995;1121-1130.
49. Pleskoff O., Sol N., Labrosse B., Alizon M. Human immunodeficiency virus strains differ in their ability to infect CD4+ cells expressing the rat homolog of CXCR-4 (fusin). J. Virol. 71:1997;3259-3262.
50. Popik W., Alce T.M., Au W.C. Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells. J. Virol. 76:2002;4709-4722.
51. Roggero R., Robert-Hebmann V., Harrington S., Roland J., Vergne L., Jaleco S., Devaux C., Biard-Piechaczyk M. Binding of human immunodeficiency virus type 1 gp120 to CXCR4 induces mitochondrial transmembrane depolarization and cytochrome c-mediated apoptosis independently of Fas signaling. J. Virol. 75:2001;7637-7650.
52. Salzwedel K., Berger E.A. Cooperative subunit interactions within the oligomeric envelope glycoprotein of HIV-1: functional complementation of specific defects in gp120 and gp41. Proc. Natl. Acad. Sci. U. S. A. 97:2000;12794-12799.
53. Siddiqi M.A., Tachibana M., Ohta S., Ikegami Y., Tahara-Hanaoka S., Huang Y.Y., Shinohara N. Comparative analysis of the gp120-binding area of murine and human CD4 molecules. J. Acquir. Immune Defic. Syndr. Human Retrovirol. 14:1997;7-12.
54. Simen A.A., Miller R.J. Structural features determining differential receptor regulation of neuronal Ca channels. J. Neurosci. 18:1998;3689-3698.
55. Simen A.A., Lee C.C., Simen B.B., Bindokas V.P., Miller R.J. The C terminus of the Ca channel alpha1B subunit mediates selective inhibition by G-protein-coupled receptors. J. Neurosci. 21:2001;7587-7597.
56. Stantchev T.S., Broder C.C. Human immunodeficiency virus type-1 and chemokines: beyond competition for common cellular receptors. Cytokine Growth Factor Rev. 12:2001;219-243.
57. Staudinger R., Wang X., Bandres J.C. HIV-1 envelope is a neutral antagonist to CXCR4 in T-cells. Biochem. Biophys. Res. Commun. 280:2001;1003-1007.
58. Sullivan N., Sun Y., Sattentau Q., Thali M., Wu D., Denisova G., Gershoni J., Robinson J., Moore J., Sodroski J. CD4-induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization. J. Virol. 72:1998;4694-4703.
59. Tarasova N.I., Stauber R.H., Michejda C.J. Spontaneous and ligand-induced trafficking of CXC-chemokine receptor 4. J. Biol. Chem. 273:1998;15883-15886.
60. Turner L., Ward S.G., Westwick J. RANTES-activated human T lymphocytes. A role for phosphoinositide 3-kinase. J. Immunol. 155:1995;2437-2444.
61. Turner S.J., Domin J., Waterfield M.D., Ward S.G., Westwick J. The CC chemokine monocyte chemotactic peptide-1 activates both the class I p85/p110 phosphatidylinositol 3-kinase and the class II PI3K-C2alpha. J. Biol. Chem. 273:1998;25987-25995.
62. Ullrich C.K., Groopman J.E., Ganju R.K. HIV-1 gp120- and gp160-induced apoptosis in cultured endothelial cells is mediated by caspases. Blood. 96:2000;1438-1442.
63. Weissman D., Rabin R.L., Arthos J., Rubbert A., Dybul M., Swofford R., Venkatesan S., Farber J.M., Fauci A.S. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor. Nature. 389:1997;981-985.
64. Whistler J.L., Chuang H.H., Chu P., Jan L.Y., von Zastrow M. Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction. Neuron. 23:1999;737-746.
65. Wyatt R., Kwong P.D., Desjardins E., Sweet R.W., Robinson J., Hendrickson W.A., Sodroski J.G. The antigenic structure of the HIV gp120 envelope glycoprotein. Nature. 393:1998;705-711.